Device evaluation: the unknown rpn zilver ptx drug eluting peripheral stent of unknown lot number involved in this complaint was implanted in the patient and was not available for evaluation.Several attempts were made to obtain additional information regarding this device.However, no response has been received to date.With the information provided, a document-based investigation was conducted.As the rpn and lot number of the complaint stent is unknown, a review of the relevant manufacturing records cannot be conducted.However, prior to distribution all zilver ptx devices are subject to visual a visual inspection and functional checks to ensure device integrity.These inspections and functional checks are outlined in internal procedures in place at cirl. as per the instructions for use, ifu0118-6, which accompanies this device it informs the user "potential adverse events that may occur include, but are not limited to, the following: restenosis of the stented artery".There is not sufficient evidence to suggest that the customer did not follow the instructions for use.A definitive root cause could not be determined from the available information.Typically the most likely root cause is attributed to patient pre-existing/underlying conditions.Although the patient pre-existing/underlying conditions are unknown we know that restenosis of the stented artery is a known potential adverse event within the ifu and is a common adverse event of endovascular procedures that can be caused by injury to the vessel (e.G.During percutaneous transluminal angioplasty (pta) and/or stenting).Vessel injury provokes an inflammatory response that leads to or amplifies the restenosis process.It may be noted that the surface of the zilver ptx stent is coated with the drug paclitaxel to help prevent subsequent restenosis of the artery. summary: the complaint is confirmed based on customer testimony.According to the initial reporter, the user had to subsequently place another stent inside the occluded stent.Complaints of this nature will continue to be monitored for potential emerging trends.
|